Azienda USL della Romagna

Ravenna 48121

0 studies enrolling now · 3 studies all time

What they study most

ALK-positive Advanced NSCLC, Paroxysmal Nocturnal Hemoglobinuria, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Studies at this site

• A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia — Running, not enrolling
• A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib — Completed
• A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH — Completed